CARA


Canaccord Predicts Over 100% Rally for These 3 “Strong Buy” Stocks

After passing one speed bump, is the market heading towards more bumps in the road? Following the September sell-off, there has been a …

3 Beaten-Down Biotech Stocks With Catalysts Just Around the Corner

With the outbreak of the coronavirus, volatility has become a seemingly ever-present facet of the stock market. Since the end of February, the …

Canaccord Confident on Cara Therapeutics (CARA) Thanks to Strong New Collaborator

Canaccord’s Arlinda Lee cheers a new deal between Cara and VFMCRP that relieves financial pressure on the stock.

Laidlaw Sheds Light on Cara Therapeutics (CARA) as It Scores Key Licensing Alliance

Laidlaw’s Francois Brisebois sings the praises of Cara’s significant licensing win as a doorway to commercial expertise and more credibility.

2 Biotech Stocks on Analysts’ Radar: Cara Therapeutics Inc (CARA) and AVEO Pharmaceuticals, Inc. (AVEO)

New insights emerge in the biotech sector as Cara Therapeutics Inc (NASDAQ:CARA) released mixed results from a phase 2b trial of the company’s pain medication, …

Cara Therapeutics Inc (CARA) Investors Spooked by Disappointing Phase 2 Trial

Cara Therapeutics Inc (NASDAQ:CARA) reported mixed top-line Ph2b results of oral CR845 in osteoarthritis (OA) with patients receiving the top 5mg dose showing …

Cantor Adjusts Price Target For Cara Therapeutics Inc (CARA) To Reflect Recent Share Dilution

In a research note issued Friday, Cantor analyst Chiara Russo reiterated an Overweight rating on shares of Cara Therapeutics Inc (NASDAQ:CARA), while lowering …

Brokerage Updates: Peregrine Pharmaceuticals (PPHM), Sarepta Therapeutics Inc (SRPT) and Cara Therapeutics Inc (CARA) on Focus

Analysts are weighing in on biotechnology firms Peregrine Pharmaceuticals (NASDAQ:PPHM), Sarepta Therapeutics Inc (NASDAQ:SRPT), and Cara Therapeutics Inc (NASDAQ:CARA). Here’s a quick roundup of today’s …

Analysts Weigh In On Two Collapsing Biotechs: Peregrine Pharmaceuticals (PPHM), Cara Therapeutics Inc (CARA)

Friday turned out to be a nightmare for shareholders of drug makers Peregrine Pharmaceuticals (NASDAQ:PPHM) and Cara Therapeutics Inc (NASDAQ:CARA), as the stocks price tumbled sharply in the wake …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts